Skip to main content
. 2017 May 23;8(43):75617–75626. doi: 10.18632/oncotarget.18118

Figure 2. Overallsurvival for patients with TNBC receiving standard chemotherapy (solid line) or standard chemotherapy plus carboplatin (dashed line).

Figure 2

Chisq = 1.6 on 1 degrees of freedom, p = 0.208.